Title:
Pepsin Assisted Doxorubicin Delivery from Mesoporous Silica Nanoparticles Downsizes Solid Tumor Volume and Enhances Therapeutic Efficacy in Experimental Murine Lymphoma

dc.contributor.authorPrateek Srivastava
dc.contributor.authorSumit Kumar Hira
dc.contributor.authorUttam Gupta
dc.contributor.authorVivek Kumar Singh
dc.contributor.authorRanjeet Singh
dc.contributor.authorPankaj Pandey
dc.contributor.authorDivesh Narayan Srivastava
dc.contributor.authorRam Adhar Singh
dc.contributor.authorPartha Pratim Manna
dc.date.accessioned2026-02-07T08:44:14Z
dc.date.issued2018
dc.description.abstractPepsin, a digestive enzyme, plays an important role in the metabolism of protein products in the stomach. The pH is regarded as the most pivotal criteria in appraising the pepsin's enzymatic activity. Pepsin is idle at the physiological pH (7.4) but dynamic in the acidic environments of the stomach (pH 2.0-4.0). Inspired by such pH regulatory actions, we have used pepsin as an enhancer, which is attached to silica nanoparticles for the doxorubicin release in the acidic tumor environment. Pepsin enzyme is transitional between the doxorubicin loaded silica nanoparticles and the biotin-avidin cap system, which intercedes the pores. The formed nanoplatform is poised at the physiological pH. However, when switched to low pH simulated conditions, the pepsin become vibrant and cleaves the avidin, rendering the clearance of the path for the diffusion of the drug. This design strategy augmented the drug bioavailability deep inside the solid tumor with enhanced uptake and apoptosis of the tumor cells in experimental lymphoma. Copyright © 2018 American Chemical Society.
dc.identifier.doi10.1021/acsabm.8b00559
dc.identifier.issn25766422
dc.identifier.urihttps://doi.org/10.1021/acsabm.8b00559
dc.identifier.urihttps://dl.bhu.ac.in/bhuir/handle/123456789/31569
dc.publisherAmerican Chemical Society
dc.subjectbiotin-avidin
dc.subjectdoxorubicin
dc.subjectmesoporous silica
dc.subjectpepsin
dc.subjectsolid tumor
dc.titlePepsin Assisted Doxorubicin Delivery from Mesoporous Silica Nanoparticles Downsizes Solid Tumor Volume and Enhances Therapeutic Efficacy in Experimental Murine Lymphoma
dc.typePublication
dspace.entity.typeArticle

Files

Collections